These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1300447)

  • 1. Increased lipoprotein (a) levels in subjects with chronic renal failure on hemodialysis.
    Barbagallo CM; Averna MR; Scafidi V; Galione A; Notarbartolo A
    Nephron; 1992; 62(4):471-2. PubMed ID: 1300447
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoprotein(a) levels in hemodialysis patients: relation to glucose intolerance and hemodialysis duration.
    Fiorini F; Masturzo P; Mij M; Bertolini S
    Nephron; 1995; 70(4):500-1. PubMed ID: 7477660
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lipoprotein(a) and lipids in chronic renal insufficiency and kidney transplant].
    Ochoa-Sosa CA; Mondragón-Rodríguez G; Zamora-González J; Cardoso-Saldaña G; Herrera-Acosta J; Posadas-Romero C
    Rev Invest Clin; 1998; 50(4):301-6. PubMed ID: 9830317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein (a) levels in end-stage renal failure and renal transplantation.
    Barbagallo CM; Averna MR; Sparacino V; Galione A; Caputo F; Scafidi V; Amato S; Mancino C; Cefalù AB; Notarbartolo A
    Nephron; 1993; 64(4):560-4. PubMed ID: 8366981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipoprotein(a) levels in patients having chronic renal failure with and without diabetes mellitus.
    Makino K; Josephson MA; Fellner SK; Scanu AM
    Atherosclerosis; 1993 Jan; 98(2):255-6. PubMed ID: 8457265
    [No Abstract]   [Full Text] [Related]  

  • 6. Lp(a) is increased in hemodialysis patients according to the type of dialysis membrane: a 2-year follow-up study.
    Diop ME; Viron B; Bailleul S; Lefevre G; Fessi H; Maury J; Etienne J; Couderc R
    Clin Nephrol; 2000 Sep; 54(3):210-7. PubMed ID: 11020019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
    Zwolińska D; Szprynger K
    Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis.
    Parra HJ; Mezdour H; Cachera C; Dracon M; Tacquet A; Fruchart JC
    Clin Chem; 1987 May; 33(5):721. PubMed ID: 2952378
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipoprotein (a) in patients on hemodialysis.
    Díaz-Peromingo JA; Carbajal DG; Albán-Salgado A
    Acta Med Austriaca; 2004 Aug; 31(3):73-5. PubMed ID: 15515480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein (a) in chronic renal failure patients undergoing hemodialysis: does it have an independent role in the development of further cardiovascular complications?
    del Cura J; Gil-Paraiso A; Borque L; Carazo ME; Maside C; Sánchez-Casajús A
    Nephron; 1993; 65(4):644-5. PubMed ID: 8302428
    [No Abstract]   [Full Text] [Related]  

  • 11. Coagulation activation in extracorporeal hemodialysis.
    Camici M; Evangelisti L; Balestri P; Cioni L; Rindi P; Sagripanti A; Meriggioli M; Giordani R
    Int J Artif Organs; 1997 Mar; 20(3):163-5. PubMed ID: 9151152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.
    Querfeld U; Lang M; Friedrich JB; Kohl B; Fiehn W; Schärer K
    Pediatr Res; 1993 Dec; 34(6):772-6. PubMed ID: 8108191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipoprotein (a) levels in maintenance hemodialysis patients.
    Okura Y; Saku K; Hirata K; Zhang B; Liu R; Ogahara S; Naito S; Kajiyama G; Arakawa K
    Nephron; 1993; 65(1):46-50. PubMed ID: 8413789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
    Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC
    Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of haemodialysis and peritoneal dialysis on serum lipoprotein(a) and C-reactive protein levels.
    Borazan A; Ustün H; Yilmaz A
    J Int Med Res; 2003; 31(5):378-83. PubMed ID: 14587304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) and vascular access survival in patients on chronic hemodialysis.
    Hernández E; Praga M; Alamo C; Araque A; Morales JM; Alcazar JM; Ruilope LM; Rodicio JL
    Nephron; 1996; 72(2):145-9. PubMed ID: 8684517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) in chronic renal disease.
    Stenvinkel P; Berglund L
    Miner Electrolyte Metab; 1996; 22(1-3):16-21. PubMed ID: 8676811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the nicotinic acid analogue niceritrol on lipoprotein Lp(a) and coagulation-fibrinolysis status in patients with chronic renal failure on hemodialysis.
    Shoji T; Nishizawa Y; Kawasaki K; Tabata T; Matsushita Y; Inoue T; Morii H
    Nephron; 1997; 77(1):112-3. PubMed ID: 9380227
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: influence of apolipoprotein (a) genetic polymorphism.
    Auguet T; Sentí M; Rubiés-Prat J; Pelegrí A; Pedro-Botet J; Nogués X; Romero R
    Nephrol Dial Transplant; 1993; 8(10):1099-103. PubMed ID: 8272223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.